Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Drug Resistance

Free Subscription Articles published in J Virol Retrieve available abstracts of 36 articles: HTML format Text format

Single Articles

November 2009
1. AMINI-BAVIL-OLYAEE S , Vucur M, Luedde T, Trautwein C, et al
   Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant Hepatitis B Virus e Antigen-positive and -negative strains.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CHERWA JE JR , Sanchez-Soria P, Wichman HA, Fane BA, et al
   Viral adaptation to an antiviral protein enhances the fitness level to above that of the uninhibited wild type.
   J Virol. 2009;83:11746-50.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
3. OGERT RA , Ba L, Hou Y, Buontempo C, et al
   Structure-function analysis of HIV-1 gp120 amino acid mutations associated with resistance to the CCR5 co-receptor antagonist vicriviroc.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. FRANSEN S , Gupta S, Danovich R, Hazuda D, et al
   Loss of Raltegravir Susceptibility of HIV-1 is Conferred by Multiple Non-overlapping Genetic Pathways.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
5. HURT AC , Holien JK, Parker M, Kelso A, et al
   Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. QUERCIA R , Dam E, Perez-Bercoff D, Clavel F, et al
   Selective advantage profile of HIV-1 integrase mutants explain in vivo evolution of raltegravir resistance genotypes.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. PARRY CM , Kohli A, Boinett CJ, Towers GJ, et al
   Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor Resistant HIV-1.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. VAN MARCK H , Dierynck I, Kraus G, Hallenberger S, et al
   The impact of individual HIV-1 protease mutations on drug susceptibility is highly influenced by complex interactions with the background protease sequence.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. VERMEIRE K , Van Laethem K, Janssens W, Bell TW, et al
   HIV-1 Escape from CADA-induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility.
   J Virol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   June 2009
10. DELVIKS-FRANKENBERRY KA , Nikolenko GN, Maldarelli F, Hase S, et al
    Subtype-Specific Differences in the HIV-1 Reverse Transcriptase Connection Subdomain of CRF01_AE are Associated with Higher AZT Resistance.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SASKOVA KG , Kozisek M, Rezacova P, Brynda J, et al
    Molecular Characterization of Clinical Isolates of HIV Resistant to the Protease Inhibitor Darunavir.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. BANKE S , Lillemark MR, Gerstoft J, Obel N, et al
    Positive Selection Pressure Introduces Secondary Mutations at the Gag Cleavages Sites in HIV-1 Harboring Major Protease Resistance Mutations.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PAN C , Cai L, Lu H, Qi Z, et al
    Combinations of the first and next generation HIV fusion inhibitors exhibit highly potent synergistic effect against enfuvirtide-sensitive and resistant HIV-1 strains.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
14. PUERTAS MC , Buzon MJ, Artese A, Alcaro S, et al
    Effect of the HIV-1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. IBARRA KD , Pfeiffer JK
    Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.
    J Virol. 2009;83:4538-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
16. ADAMSON CS , Waki K, Ablan SD, Salzwedel K, et al
    IMPACT OF HUMAN IMMUNODEFICIENCY VRIUS TYPE 1 RESISTANCE TO PROTEASE INHIBITORS ON EVOLUTION OF RESISTANCE TO THE MATURATION INHIBITOR BEVIRIMAT (PA-457).
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. DUDLEY DM , Wentzel JL, Lalonde MS, Veazey RS, et al
    Selection of SHIV resistant to a vaginal microbicide in macaques.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
18. ARMSTRONG KL , Lee TH, Essex M
    Replicative Capacity Differences of Thymidine Analog Resistance Mutations in Subtype B and C HIV-1.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. NOLAN KM , Del Prete GQ, Jordan AP, Haggarty B, et al
    Characterization of an HIV-1 V3 Deletion Mutation that Confers Resistance to CCR5 Inhibitors and the Ability to Use Aplaviroc-Bound Receptor.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. AMBROSE Z , Herman BD, Sheen CW, Zelina S, et al
    The human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogs.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SOLMONE M , Vincenti D, Prosperi MC, Bruselles A, et al
    Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.
    J Virol. 2009;83:1718-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
22. AOKI M , Venzon DJ, Koh Y, Aoki-Ogata H, et al
    Non-cleavage Site Gag Mutations in Amprenavir-resistant HIV-1 Predispose HIV-1 to Rapid Acquisition of Amprenavir Resistance But Delays Development of Resistance to Other Protease Inhibitors.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. HUE S , Gifford RJ, Dunn D, Fernhill E, et al
    Demonstration of Sustained Drug-Resistant HIV-1 Lineages Circulating amongst Treatment-Naive Individuals.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. RAY N , Blackburn LA, Doms RW
    HR-2 Mutations in HIV-1 gp41 Restore Fusion Kinetics Delayed by HR-1 Mutations that Cause Clinical Resistance to Enfuvirtide.
    J Virol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
25. PAREDES R , Sagar M, Marconi VC, Hoh R, et al
    In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant HIV-1 in the Absence of Lamivudine.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. YORK J , Dai D, Amberg SM, Nunberg JH, et al
    pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors.
    J Virol. 2008;82:10932-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
27. HARRISON JE , Lynch JB, Sierra LJ, Blackburn LA, et al
    Baseline resistance of primary HIV-1 strains to the CXCR4 inhibitor AMD3100.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. MOSEBI S , Morris L, Dirr HW, Sayed Y, et al
    Active Site Mutations in the South African HIV-1 Subtype C Protease Impact Significantly on Clinical Inhibitor Binding: a Kinetic and Thermodynamic Study.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
29. MITSUYA Y , Varghese V, Wang C, Liu TF, et al
    Minority HIV-1 Variants in Antiretroviral Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. GOETHALS O , Clayton R, Van Ginderen M, Vereycken I, et al
    Resistance mutations in HIV-1 integrase selected with Elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BOUVIER NM , Lowen AC, Palese P
    Oseltamivir-Resistant Influenza A Viruses Transmit Efficiently Among Guinea Pigs by Direct Contact but not by Aerosol.
    J Virol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
32. MYERS RE , Pillay D
    Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type-1 Integrase.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
33. MARTINS AN , Medeiros SO, Simonetti JP, Schatzmayr HG, et al
    Phylogenetic and genetic analysis of Feline Immunodeficiency Virus gag, pol and env genes from domestic cats under NRTI treatment or treatment-naive circulating in Rio de Janeiro, Brazil.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
34. TSIBRIS AM , Sagar M, Gulick RM, Su Z, et al
    In vivo emergence of vicriviroc resistance in an HIV-1 subtype C-infected subject.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
35. EGGINK D , Baldwin CE, Deng Y, Langedijk JP, et al
    Selection of T1249-resistant Human Immunodeficiency Virus type 1 variants.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. KOZISEK M , Saskova KG, Rezacova P, Brynda J, et al
    Ninety Nine is Not Enough: Molecular Characterization of Inhibitor Resistant HIV-1 Protease Mutants with Insertions in the Flap Region.
    J Virol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: